Literature DB >> 16267828

Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease.

Jameel Dennis1, Luciana Nogaroli, Babette Fuss.   

Abstract

Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX) was originally identified as a cell-motility-stimulating factor secreted by a variety of tumor cells. Thus, studies related to its potential functional roles have traditionally focused on tumorigenesis. PD-Ialpha/ATX's catalytic activity, initially defined as nucleotide pyrophosphatase/phosphodiesterase, was soon recognized as being necessary for its tumor cell-motility-stimulating activity. However, only the discovery of PD-Ialpha/ATX's identity with lysophospholipase D, an extracellular enzyme that converts lysophosphatidylcholine into lysophosphatidic acid (LPA) and potentially sphingosylphosphoryl choline into sphingosine 1-phosphate (S1P), revealed the actual effectors responsible for PD-Ialpha/ATX's ascribed motogenic functions, i.e., its catalytic products. PD-Ialpha/ATX has also been detected during normal development in a number of tissues, in particular, the central nervous system (CNS), where expression levels are high. Similar to tumor cells, PD-Ialpha/ATX-expressing CNS cells secrete catalytically active PD-Ialpha/ATX into the extracellular environment. Thus, it appears reasonable to assume that PD-Ialpha/ATX's CNS-related functions are mediated via lysophospholipid, LPA and potentially S1P, signaling. However, recent studies identified PD-Ialpha/ATX as a matricellular protein involved in the modulation of oligodendrocyte-extracellular matrix interactions and oligodendrocyte remodeling. This property of PD-Ialpha/ATX was found to be independent of its catalytic activity and to be mediated by a novel functionally active domain. These findings, therefore, uncover PD-Ialpha/ATX, at least in the CNS, as a multifunctional protein able to induce complex signaling cascades via distinct structure-function domains. This Mini-Review describes PD-Ialpha/ATX's multifunctional roles in the CNS and discusses their potential contributions to CNS development and pathology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267828     DOI: 10.1002/jnr.20686

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  25 in total

Review 1.  Nucleotide signaling in nervous system development.

Authors:  Herbert Zimmermann
Journal:  Pflugers Arch       Date:  2006-04-25       Impact factor: 3.657

Review 2.  Neuron-astroglial interactions in cell-fate commitment and maturation in the central nervous system.

Authors:  Joice Stipursky; Tânia Cristina Leite de Sampaio E Spohr; Vivian Oliveira Sousa; Flávia Carvalho Alcantara Gomes
Journal:  Neurochem Res       Date:  2012-05-22       Impact factor: 3.996

3.  Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytes.

Authors:  Luciana Nogaroli; Larra M Yuelling; Jameel Dennis; Karen Gorse; Shawn G Payne; Babette Fuss
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

Review 4.  Glia unglued: how signals from the extracellular matrix regulate the development of myelinating glia.

Authors:  Holly Colognato; Iva D Tzvetanova
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

Review 5.  G-protein-coupled receptor signaling and neural tube closure defects.

Authors:  Issei S Shimada; Saikat Mukhopadhyay
Journal:  Birth Defects Res       Date:  2017-01-30       Impact factor: 2.344

Review 6.  Autotaxin, a lysophospholipase D with pleomorphic effects in oncogenesis and cancer progression.

Authors:  Lorenzo Federico; Kang Jin Jeong; Christopher P Vellano; Gordon B Mills
Journal:  J Lipid Res       Date:  2015-05-14       Impact factor: 5.922

7.  Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes.

Authors:  Yona Goldshmit; Rosalia Matteo; Tamar Sztal; Felix Ellett; Frisca Frisca; Kelli Moreno; Duncan Crombie; Graham J Lieschke; Peter D Currie; Roger A Sabbadini; Alice Pébay
Journal:  Am J Pathol       Date:  2012-07-20       Impact factor: 4.307

8.  Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma.

Authors:  Jian-Min Wu; Yan Xu; Nicholas J Skill; Hongmiao Sheng; Zhenwen Zhao; Menggang Yu; Romil Saxena; Mary A Maluccio
Journal:  Mol Cancer       Date:  2010-03-31       Impact factor: 27.401

Review 9.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 10.  Purinergic signaling in oligodendrocyte development and function.

Authors:  Taylor G Welsh; Sarah Kucenas
Journal:  J Neurochem       Date:  2018-03-25       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.